Back to Search
ERIN PEREZ, MD
MD
Pediatrics Physician
NPI: 1568104529Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.
PMID 19159743·J Pediatr Surg·2009
8-other
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
PMID 18443902·Breast Cancer Res Treat·2009
6-review
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.
PMID 19671735·Mol Cancer Ther·2009
6-review
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
PMID 18777950·Clin Breast Cancer·2008
6-review
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.
PMID 18587387·Nat Biotechnol·2008
7-preclinical
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3292 E Bend Dr Apt 101
Portage, IN 46368 - Phone
- (219) 402-9123
Quick Facts
- NPI
- 1568104529
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile